DIP Episode 174 - USMLE Step 2CK Rapid Review Series 22 (IM)
Topic
Infectious disease (Coxiella); Metabolic disorders (Carcinoid Syndrome, Folate deficiency); Connective tissue disorders (Ehlers-Danlos Syndrome)...
Key Takeaway
High-yield board concepts include recognizing Coxiella burnetii in culture-negative endocarditis, understanding the metabolic cascade leading to pellagra in carcinoid syndrome, and recalling specific toxicities associated with chemotherapy agents (e.g., pulmonary fibrosis from bleomycin/MTX).
Episode Notes
Source / episode info
- Episode: 174
- Title: Divine Intervention Episode 174 – USMLE Step 2 CK Rapid Review Series 22 (IM).
- Published: 2019-10-21
- Source: Episode page
One-liner
This episode reviews high-yield board associations covering culture-negative endocarditis (Coxiella burnetii), the metabolic consequences of carcinoid syndrome (pellagra), connective tissue defects (Ehlers-Danlos Syndrome), specific chemotherapeutic toxicities (pulmonary fibrosis, neuropathy), and diagnostic workups for GI/hematologic issues.
High-yield summary
- Endocarditis: When considering culture-negative endocarditis, especially in a patient with fever, think of Coxiella burnetii (Q fever).
- Carcinoid Syndrome: The release of excessive serotonin (5-HT) from a small bowel tumor depletes Tryptophan needed for Niacin synthesis, leading to the "4 Ds of Pelagra": Diarrhea, Dermatitis, Dementia, and Death.
- Ehlers-Danlos Syndrome (EDS): Beyond typical vascular issues, remember that EDS patients are at high risk for small bowel perforation/explosion due to defective collagen membranes.
- Macrocytic Anemia: A macrocytic anemia (high MCV) in a patient with hemolytic or chronic GI blood loss must prompt testing for Folate deficiency, not just B12 deficiency. Alcoholism is also a cause due to impaired folate reabsorption.
- Chemo Toxicity: Pulmonary fibrosis from anti-cancer agents requires remembering the triad: Bleomycin, Cisplatin, and Methotrexate. Methotrexate bone marrow suppression can be reversed with Leucovorin (folinic acid).
Learning objectives
- Identify the specific organisms associated with culture-negative endocarditis (e.g., Coxiella burnetii ).
- Explain the metabolic pathway linking carcinoid syndrome, serotonin release, and pellagra development.
- Recognize the high-risk complications of connective tissue disorders like Ehlers-Danlos Syndrome, particularly GI perforation risk.
- Differentiate between causes of macrocytic anemia (B12 vs Folate) and identify specific clinical triggers for folate deficiency (alcoholism, hemolysis).
- Recall the classic triad of chemotherapeutic agents causing pulmonary fibrosis and their respective mechanisms/toxicities.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Coxiella burnetii | Culture-negative endocarditis; Q fever | Endocarditis, zoonotic source (livestock) | Always consider this when routine blood cultures are negative. |
| Carcinoid Syndrome | Diarrhea, Dermatitis, Dementia (4 Ds of Pelagra) | Serotonin excess -> Niacin deficiency | The metabolic link is key: 5-HT depletes Tryptophan needed for Niacin synthesis. |
| Ehlers-Danlos Syndrome | Small bowel perforation/explosion risk | Collagen defect in connective tissue | Remember the GI tract fragility, not just vascular issues. |
| Folate Deficiency | Macrocytic anemia (Megaloblastic) | Hemolysis; Alcoholism (impaired ileal absorption) | When presented with macrocytic anemia, always rule out folate deficiency alongside B12. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Endocarditis | Coxiella burnetii | Culture-negative endocarditis; Q fever | High yield for board exams, especially in atypical presentations. |
| Carcinoid Syndrome | 4 Ds of Pelagra (Dermatitis, Diarrhea, Dementia, Death) | Serotonin excess from GI tumor -> Niacin deficiency | Tests understanding of metabolic pathways and nutritional deficiencies. |
| Ehlers-Danlos Syndrome | Small bowel perforation risk | Collagen defect; Autosomally dominant inheritance | Requires thinking beyond classic vascular complications (aortic dissection). |
| Macrocytic Anemia | Folate Deficiency vs B12 Deficiency | Hemolysis, Alcoholism | A common trap question: always consider folate deficiency in these settings. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| Patient presents with fever, endocarditis, but blood cultures are negative. | Coxiella burnetii Endocarditis | This organism is a classic cause of culture-negative endocarditis and is associated with Q fever. |
| Small bowel tumor causes excessive serotonin release, leading to diarrhea, dermatitis, and dementia. | Carcinoid Syndrome -> Pellagra | Serotonin depletes Tryptophan needed for Niacin synthesis (B3), causing the classic 4 Ds of Pelagra. |
| Patient with a history of abdominal surgery develops acute obstruction; imaging shows bowel contents scattered throughout the GI tract. | Ehlers-Danlos Syndrome (EDS) | EDS is a collagen defect, leading to fragile membranes and high risk for small bowel perforation/explosion. |
| A patient has macrocytic anemia following chronic blood loss from an unknown source. | Folate Deficiency | While B12 deficiency also causes megaloblastic anemia, the transcript emphasizes that folate deficiency is often missed and can be caused by hemolysis or alcoholism (impaired ileal absorption). |
| Patient develops shortness of breath and dry cough after receiving chemotherapy for colon cancer; CT shows increased interstitial markings. | Bleomycin/Cisplatin/Methotrexate Toxicity -> Pulmonary Fibrosis | These three agents are the classic triad causing drug-induced pneumonitis/fibrosis, presenting as a restrictive pattern. |
| Patient with chronic left lower quadrant pain and fever requires imaging. | Diverticulitis | Initial workup is CT Abdomen with IV contrast. Crucially, follow-up colonoscopy must occur 6 weeks after the acute episode to rule out pseudo-diverticulitis/colon cancer. |
Differential diagnosis / distinguishing features
Chemotherapy-Induced Pulmonary Fibrosis
| Key Features | Distinguishing Findings | Next Step |
| Bleomycin/Cisplatin/Methotrexate | Restrictive lung disease pattern (FEV1/TLC normal or high); Interstitial markings on CT. | Identify the causative drug; Monitor pulmonary function and consider supportive care. |
Acute Abdominal Pain (Diverticulitis vs Cancer)
| Key Features | Distinguishing Findings | Next Step |
| Acute Diverticulitis | LLQ pain, fever, localized inflammation on CT. | Initial workup: CT Abdomen w/ IV contrast. Manage acutely. |
| Colon Cancer (Pseudo-diverticulitis) | Can mimic diverticulitis presentation; Often asymptomatic until advanced. | Crucial: Perform colonoscopy 6 weeks after acute episode resolves to rule out malignancy. |
Management pearls
- For suspected endocarditis with negative blood cultures, consider Coxiella burnetii (Q fever) as a key differential diagnosis.
- In patients with carcinoid syndrome, the underlying metabolic issue is Niacin deficiency due to 5-HT depletion; treatment involves managing the tumor and supplementing B3/folate.
- When evaluating macrocytic anemia, especially in alcoholics or those with chronic GI bleeding, always test for Folate deficiency because impaired ileal absorption is a common cause.
- Following an acute episode of diverticulitis, a colonoscopy must be performed 6 weeks later to rule out underlying colorectal cancer (pseudo-diverticulitis).
Don't miss
Integration & clinical reasoning
- Metabolic/Endocrine Integration: Understanding how a metabolic disorder (Carcinoid Syndrome -> Niacin deficiency) can mimic or cause symptoms related to nutritional deficiencies is critical, similar to how folate deficiency mimics B12 deficiency in macrocytic anemia.
- GI Pathology Integration: The risk of small bowel perforation in EDS and the need for colonoscopy follow-up after diverticulitis highlight that connective tissue defects and GI malignancy must be considered when evaluating abdominal pain/obstruction.
- Oncology Integration: Recognizing the specific toxicities (pulmonary fibrosis, neuropathy) associated with different classes of anti-cancer drugs is a high-yield pattern on board exams.
OMM / COMLEX integration
- Standard emergency management takes priority over OMT in acute abdominal pathology (e.g., suspected bowel perforation from EDS or acute diverticulitis).
- For any patient presenting with signs of severe systemic illness (sepsis, GI bleed), initial stabilization and broad-spectrum antibiotics/fluids are paramount; OMT is adjunctive only after the primary life threat is managed.
Concept connections / cross-references
- For more detailed coverage of connective tissue disorders and vascular complications, review [ Episode 102 ].
- For comprehensive reviews of GI pathology and colon cancer screening guidelines, see [ Episode 34 ].
- For general principles of infectious disease workups and atypical pathogens, refer to [ Episode 58 ].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Coxiella burnetii | Culture-negative endocarditis; Q fever | Zoonotic infection (livestock exposure) | Requires specific serology/treatment, as routine cultures are negative. |
| Carcinoid Syndrome | Serotonin excess -> Niacin deficiency | 5-HT depletes Tryptophan needed for Niacin synthesis. | Leads to the classic "4 Ds of Pelagra." |
| Ehlers-Danlos Syndrome (EDS) | Small bowel perforation/rupture | Defective collagen structure in connective tissue. | High risk of GI catastrophe, requiring careful surgical planning and monitoring. |
| Methotrexate Toxicity | Bone marrow suppression -> Leucovorin rescue | MTX inhibits dihydrofolate reductase; Leucovorin bypasses this inhibition. | Essential knowledge for managing chemotherapy side effects. |
Key terms glossary
| Term | Definition | Context | Example |
| Coxiella burnetii | Obligate intracellular bacterium causing Q fever. | Endocarditis, zoonotic infection. | Found in livestock; causes culture-negative endocarditis. |
| Pelagra | Dermatological syndrome caused by Niacin (B3) deficiency. | Carcinoid Syndrome/Metabolic disorder. | Characterized by the 4 Ds: Diarrhea, Dermatitis, Dementia, Death. |
| Ehlers-Danlos Syndrome (EDS) | Group of inherited connective tissue disorders affecting collagen synthesis. | Connective Tissue Disorders. | High risk for vascular rupture and small bowel perforation. |
| Leucovorin | Folinic acid; a reduced form of folate. | Chemotherapy rescue therapy. | Used to counteract the bone marrow suppression caused by Methotrexate. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Metabolic/Nutritional Deficiencies | Focus on metabolic cascades (e.g., 5-HT -> Niacin). | High | Review the "4 Ds" and the specific nutrient depletion mechanisms. |
| Oncology Toxicity | Create a drug-toxicity matrix (Drug: Target Organ: Side Effect). | High | Must memorize the triad for pulmonary fibrosis (Bleo, Cis, MTX) and their respective rescue agents/mechanisms. |
| GI Pathology Workup | Master the "when" and "why" of follow-up procedures (e.g., 6 weeks post-diverticulitis). | Medium | Focus on differentiating acute vs chronic presentations and necessary surveillance colonoscopies. |
Question pattern recognition
- The Metabolic Cascade Pattern: Identifying a primary defect (e.g., tumor release) that leads to the depletion of a secondary metabolite, causing a deficiency syndrome (Carcinoid -> Niacin).
- The "Must Rule Out" Pattern: In any patient presenting with vague symptoms (e.g., macrocytic anemia, abdominal pain), always list the most dangerous or treatable cause first (e.g., colon cancer, folate deficiency).
- The Triad/Classic Association Pattern: Memorizing groups of drugs or conditions that are almost always seen together (Bleomycin/Cisplatin/MTX; 4 Ds of Pelagra).
Test yourself
Common mistakes to avoid
Common traps
Original transcript with highlights
Original transcript with highlights
Okay, welcome. My name is Divine. This is going to be, I believe, episode 174 of the Divine Intervention Podcasts. And in this podcast, I'm going to be continuing the Rapid Review series for the USM list of 1x. I mean, the USM list of 2 CK exam. This will be series 22. Okay, so this episode 174 series 22. So let's go ahead and get right into it. So what if you get a question about a patient? And this patient has, this patient has, an endocarditis. And they tell you that this person has, you know, is like a cattle farmer. And they tell you that, you know, you do like the classic blood cultures and you're not green anything. What book should you be thinking about on that those circumstances? I really hope that you're thinking about, I really hope that you're thinking about coxiella, coxiella, bonedia. Okay, remember coxiella, bonedia is a very common cause of like a culture negative endocarditis. You know, back in the day where there was this stuff with the Hisek organism, so like Himophlas, Atino Bacelos, Cario Bacterium, Iconela and Kingella. But the usually don't go there and then BAME exams these days. And I'll go after like weird exotic things like coxiella, bonedia. Remember coxiella tends to cause like, cue fever, right? So again, that's a big thing. You want to keep at the back of your mind for tests. Now, what if they give you a question about a patient and they tell you that this patient has a history of like, carstenoid syndrome.
And this person has, you know, become forgetful. And this person's cause like a 20 out of 30 on a mini mental status exam. And this person, you know, has been having like chronic diarrhea. And this person, you know, has like these like skin, like these like weird rashes on the skin. What are you thinking about on the other circumstances? Well, I really hope that you're thinking about a really hope that you're thinking about like a pelagra, right? So because this person has carstenoid syndrome, remember, for person has carstenoid syndrome, it essentially involves the person making having a tumor, usually it's in the small ball, usually in the appendix that's making a ton of serotonin. And that serotonin, remember serotonin, another name for serotonin is 5 HT or 5 hydroxychromotophane. So the thing that's essentially happening is that you're converting the, you're converting trip, like trip to fun to serotonin. But remember that trip to fun is also needed for the production of niacin. So if a person has serotonin syndrome and you are consuming all their trip to fun in the production of serotonin, then you have less trip to fun, aka feedstock available for the production of niacin. And that can ultimately cause problems for the patient, right? That can cause the 4 Ds of pelagra, which in this case will be diarrhea, dermatitis, dementia and death. So those are all high yield things you want to keep at the back of your mind with exams.
Now, what if they give you a question about a patient? And this patient, you know, they tell you that this patient has, this patient, you know, was initially complaining of, let's say this patient has like a history of like this, they've had like some kind of like abdominal surgery. And then they tell you that this person, you know, has been having like fevers and this person has not been passing flatus and this person has been having like a lot of vomiting. So basically like signs and symptoms of a small bowel obstruction. And then they tell you that this person, you know, keeps having like abdominal distension, distension, distension. And they tell you that all of a sudden the person loses consciousness, becomes profoundly hypotensive and dies. And then they tell you that when the obtain imaging, like maybe let's say they obtained like emergent imaging or something, and they notice like bowel contents all thrown around the GI tract. What's your diagnosis there? What genetic condition does that person have? Well, I would really hope that you're thinking about something along the lines of Elisdanlo syndrome, right? So the thing is classically right, when people think of Elisdanlo syndrome, or they think about other cardiac issues that they can have. So you know, most people tend to think about like, oh, this person has Elisdanlo's, which is like, you know, it can be like a type three or type five collagen defect.
And they're like, oh, if this person can have like aortic dissection, because remember, it's a connective tissue disorder, or they can have like a thoracic aortic aneurysm, or they can have like a mitral valve prolapse. Those are like the big things people have come to associate with Elisdanlo syndrome. But the thing is, in general, in Elisdanlo, those people can actually have like essentially like explosion of their small balls, right? So that's actually a very high-yield thing you want to keep at the back of your mind, for example. They can have explosions of their small balls, right? So they like, essentially like their small balls just literally explodes, because again, they have issues with collagen, so they don't have like strong membranes surrounding their small balls, right? So that can be a common complication. So generally, you want to like think twice about like, if a person has Elisdanlo syndrome, like some classic things you mean, or unusual things, I guess I'll put it that with some unusual things, emission and envy and examinees. You want to be careful with these people becoming pregnant. I mean, typically you try to like either like offer like very early C sections, right? And again, if you have like any abdominal process that can cause distinction, you absolutely want to be careful with those people, right? Because again, you don't want your small balls to explode. Again, that's something that's very high yields to know for the purposes of NV Me exams.
And remember that Elisdanlo syndrome is inherited in an autosomodominant fashion. And people that also have Elisdanlo syndrome believe it or not, they can also have ameurysms in the circle of Willis, right? Which can cause a subarachnoid hemorrhage when he ruptures. Now, wouldn't they give you a question about a patient? And let's see this patient, they tell you that the person has, how do I put this? So let's say this person has like a history of hair detristers like doses. What you notice that on labs, the person's MCV is like 110. What is the most likely cause of that person's elevated MCV? I mean, obviously, you know that that's a macrosylic anemia. But what's the cause on that those circumstances? Well, I would really hope that you're thinking along the lines of, you're thinking along the lines of of a, I don't know why I'm having these blanks. So I hope you're thinking along the lines of like a full-lit deficiency. I don't know what's going on maybe it's because of this headache I have. But you're thinking along the lines of a fully deficiency. Remember that full-lit is known as vitamin B9 and you can actually be run out of your full-lit a lot faster than you can run out of your B12. So they will try to trick you on the exam with a B12 deficiency as the cause of the person's macrosylic anemia. Resist that temptation. The person likely has a fully deficiency as the cause of their macrosylic anemia.
And I guess because they essentially have issues with DNA synthesis, if you want to be a little more specific, those people have a mega-loblastic anemia. So again, those are all actually high-y things you want to keep at the back of your mind for exams. People that classically get fully deficiencies are people that have like a history of like a macrosylic, like sorry, of a, of a hemolidic anemia. So hemolidic anemia tend to be associated with a fully deficiency, right? So like this person that has hair diffusers like doses has a hemolidic anemia. So they can give you the same thing as a person that has like sickle cell disease or in a person that has like one of the thalacemias, right? Essentially anything that causes a hemolidic anemia can ultimately lead to a fully deficiency. This is why people that have a hemolidic anemia need to get daily fully supplementation. Also remember if you see a macrosylic anemia in an alcoholic, you also again want to think about a fully deficiency because the enzyme that helps you reabsorb fully in the doernum of the GI tract actually depends on, actually depends on like it's actually inhibited. Sorry, I have a, I have a small headache. I don't know, I think that that may be sort of like messing with my head a little here. But the enzyme that helps you reabsorb fully in the GI tract that enzyme is poisoned by alcohol, right? So that's why alcoholics tend to develop a fully deficiency.
Now what if you get a question about a patient and this patient you know they've smoked like half a pack of cigarettes every day for like 10 years and they tell you that this patient is like 35 years old and this patient comes in because he has been having like increased put on production and they tell you that this person is you know has been having like increased put on production a lot of cough and then they tell you that on imaging of the chest like on a chest texture or like a CT scan of the chest you notice that this person has like hyperinflation like mild not severe mild hyperinflation of the lungs and then they tell you that the person's uncle died of some liver problem about 20 or 30 years ago. What diagnosis are you thinking about on that circumstances? Well, I would really hope that you're thinking about a patient with alpha-1 antitripsin deficiency, right? Remember alpha-1 antitripsin deficiency is inherited in an autosomal code dominant fashion, right? And when people have alpha-1 antitripsin deficiency they tend to have liver problems and lung problems, right? Because I mean if you think about the pathophysiology remember A1-E-T deficiency, right? E-O-1 antitripsin it's an antiprotease, right? So it essentially protects your lung from degradation by proteases, right? So if you have a deficiency of an antiprotease then that means the proteases will hold sway and that can essentially cause an infezema, okay? That can cause a panacinar infezema.
So that's again a classic presentation on the USMLA exams. One thing I will tell you is they may occasionally try to trick you with a patient that's like a teenager or a patient that's in like their 20s and they will try to get you to think of alpha-1 antitripsin deficiency as the cause of their lung pathology. I will strongly encourage you to not go with that. Even if a person has alpha-1 antitripsin deficiency, yes, that increases the risk of having like early onset infezema. But the thing is that infezema typically shows up in the early 30s or early 40s. It doesn't show up like super early like a patient having infezema essentially in their 20s on the USMLA exams. So I'll be very aware of that if I were you when you're taking when you're taking tests. Now what if they give you a question about a patient that presents with like, you know, they tell you that you know they've been having fatigue for the last couple of months and let's say this patient has smoked like, you know, two packs of cigarettes every day for like 15 years and this patient is like a 53 year old male and then they give you like a CBC and you notice that this patient's MCV is like 65 and the patient's hemoglobin is eight. What is your next best step in management for this patient? Well, I would really hope you're saying to go ahead and perform a colonoscopy, right? So remember, whenever you see a micrositic anemia in a person that is over 50 years old, right?
You always want to entertain the you always want to entertain a getting a colonoscopy, right? Because they may have colon cancer as the cause of their micrositic anemia. Okay? So a colonoscopy is the next best step in management on that those circumstances. One other thing you're friends at the MBME love to do occasionally is they may give you a question about a patient that, you know, comes in with like, you know, left lower cordion pain and fever. You know, obviously that's diverticulitis, right? And the first thing you would want to do for those people is you want to get a CT scan of the abdomen with IV contrast, right? So you get a CT scan of the abdomen with IV contrast. You make the diagnosis. One thing you should not forget to do is that weeks after about six weeks after that episode of diverticulitis, you absolutely positively want to make sure that you obtain a colonoscopy to rule out colon cancer because remember sometimes colon cancer can present like diverticulitis. That's something that's classically known as pseudo diverticulitis, okay? So that's one thing you want to try to rule out, right? So you get a colonoscopy weeks after they've had like essentially after the acute episode of diverticulitis has resolved. Do not do a colonoscopy during the acute phase of a diverticulitis because that can increase the person's risk of colonic preparation and you absolutely do not want that. So again, that's a big thing.
Big big sure thing you want to keep at the back of your mind on exams. Now, what if they give you a question about a patient you know that has like lung cancer and you know this patient was studied on pharmacologic therapy and then this patient starts complaining of like a pins and needle sensation in their upper and lower extremities. What's the drug that this patient was placed on? I would really hope you're thinking about like the VINCA alcoholoids, right? So like VIN Christine and VIN Blasting. Remember those drugs inhibit polymerization of microtubules and they tend to be associated with peripheral neuropathy as a side effect, okay? So if you ever see peripheral neuropathy as a side effect of an anti-cancer medication, yes, don't get me wrong. There are many anti-cancer medications that can cause peripheral neuropathy. What the only one I want you to think about on NBM exams at the VINCA alcoholoids like VIN Christine of VIN Blasting. Other drug classes you could potentially consider are things like your taxing, right? So like badly taxed cell and those are taxed cell. Remember those work more with preventing the depolymerization of microtubules, okay? So those are the drugs that you want to keep at the back of your mind, but really the big big one I really want you to think about when you're talking about NBM exams at the VINCA alcoholoids like VIN Christine and VIN Blasting.
Now what if you get a question about a patient and this patient, you know, recently studied treatment for some kind of malignancy and then they tell you that this patient has, like over the last, let's see, this patient studied this treatment for like some kind of colon cancer, right? And then this patient recently has studied having like shortness or breath and this patient is, you know, having like a dry cough. So like dry cough, shortness or breath and then they tell you that oh, in worry they obtain like a CT scan of the chest and then they tell you that you see increased interstitial markings on chest imaging. What kind of drug was this patient recently studied on? Well, I would really hope you're thinking about actually one of like, you know, three options. So something like the sofa, right? Or bleomising or methyl tracksit, okay? The sofa and bleomising or methyl tracksit, right? Because this person very likely has pulmonary fibrosis, pulmonary fibrosis in the setting of either like the sofa, bleomising or methyl tracksit toxicity. And remember that when a person has pulmonary fibrosis, right? They will essentially present with a restrictive lung disease picture. So if you measure their FEV1 to every C-reachers, it will be normal or mildly increased on an MBM exam, right? And those increased interstitial markings and referring to is just essentially the long fibrosis that the person has undergone from taking one of these agents, right?
The thing is cancer drugs and their side effects are very, very high or to know for the purposes of the USMLA exams, right? So don't forget your bleomising, your buisulfen and your methyl tracksit as causes of pulmonary fibrosis in the setting of anti-cancer therapy. And some key things you actually want to know with those drugs, right? You want to know that bleomising specifically works in the G2 phase of the cell cycle, right? And then you want to know that methyl tracksit works by inhibiting the enzyme dihydrofolid reductis, dihydrofolid reductis. So by inhibiting dihydrofolid reductis, that will mess up the any synthesis and that will prevent proliferation of the malignancy. Although you also want to store in the back of your mind that if a person has like a profound bone marrow suppression from taking methyl tracksit, right? What is the drug of choice to rescue those people's bone marrow? I would hope you're telling me look of worry, remember look of worry is a forlinic, not for lemic acid and a log that is used to reverse the bone marrow-suppressive toxicity of a methyl tracksit.
And the thing is the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of th
e end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of
the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end
of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the
end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of t
he end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end o
f the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the end of the
Practice questions — USMLE style
Question 1 — Endocrinology/Nutrition
A 50-year-old man is diagnosed with a gastrointestinal tumor originating in his appendix. The tumor secretes large amounts of serotonin into the systemic circulation. Over several months, the patient develops chronic diarrhea, dermatitis, and cognitive impairment. Laboratory workup reveals signs consistent with niacin deficiency. Which metabolic pathway disruption best explains this clinical presentation?
- A) Increased utilization of Vitamin B12 by the tumor leading to megaloblastic anemia.
- B) Excessive consumption of tryptophan for serotonin synthesis, thereby limiting the substrate needed for pyrimidine synthesis.
- C) Depletion of the common precursor molecule (tryptophan) required for both serotonin production and subsequent conversion into niacin.
- D) Impaired absorption of folate in the small intestine due to tumor-induced inflammation.
Answer: C. Carcinoid syndrome, particularly when involving GI tumors that release excessive serotonin (5-hydroxytryptamine or 5 HT), leads to a metabolic depletion of tryptophan. Tryptophan is a precursor for both serotonin and niacin (Vitamin B3). By diverting the available tryptophan pool into massive amounts of serotonin production, the body becomes deficient in the substrate needed to synthesize niacin, leading to pellagra—the classic triad of diarrhea, dermatitis, and dementia (the 4 Ds).
Question 2 — Hematology/Nutrition
A 68-year-old man with a history of chronic alcoholism presents for evaluation of fatigue. Physical exam reveals generalized pallor. CBC shows a hemoglobin of 9.5 g/dL and an elevated mean corpuscular volume ($\text{MCV}$) of $110 \text{ fL}$. The patient has no known history of acute bleeding or hemolysis, but the physician suspects nutritional deficiency is contributing to his anemia. What is the most likely cause of this macrocytic anemia?
- A) Vitamin B12 deficiency
- B) Folate deficiency
- C) Iron deficiency
- D) Thalassemia minor
Answer: B. Macrocytic anemia (high MCV) suggests impaired DNA synthesis, pointing toward deficiencies in folate or cobalamin ($\text{B}_{12}$). While $\text{B}_{12}$ deficiency is a common cause of macrocytic anemia, the patient's history of chronic alcoholism significantly increases the risk of folate deficiency. Alcohol impairs the absorption and metabolism of folate in the GI tract. Furthermore, while both deficiencies can present similarly, if the question emphasizes alcohol use or suggests an issue with DNA synthesis without specific neurological symptoms (which are more typical of $\text{B}_{12}$ deficiency), folate is a highly probable answer.
Question 3 — Pulmonology/Genetics
A 45-year-old male smoker presents to the clinic complaining of chronic, worsening shortness of breath and dry cough over the last year. He has a known family history of liver disease. Initial screening suggests impaired antiprotease activity. Further testing confirms a deficiency in alpha-1 antitrypsin ($\text{AAT}$). Which statement regarding $\text{AAT}$ deficiency is most accurate?
- A) The primary manifestation of $\text{AAT}$ deficiency is typically severe, early-onset emphysema due to unchecked protease activity.
- B) Liver cirrhosis and hepatitis are usually the earliest signs of disease, preceding pulmonary symptoms by decades.
- C) The deficiency results in a failure to protect lung tissue from degradation by neutrophil elastase, leading to panacinar emphysema.
- D) $\text{AAT}$ deficiency is an autosomal recessive disorder that requires prophylactic treatment with protease inhibitors.
Answer: C. Alpha-1 antitrypsin ($\text{AAT}$) is a crucial antiprotease that protects the lung parenchyma from degradation by neutrophil elastases (proteases). Deficiency leads to unchecked proteolytic activity, which primarily causes emphysema. While $\text{AAT}$ deficiency can cause both liver disease and pulmonary issues, the mechanism involves failure of protease inhibition in the lungs. Option A is incorrect because while emphysema occurs, it often presents later than suggested by "severe, early-onset." Option B is incorrect; while liver disease is common, the lung pathology (emphysema) is a hallmark complication that develops over time due to proteolysis.
Question 4 — Pharmacology/Toxicology
A patient undergoing chemotherapy for colon cancer develops shortness of breath and a persistent dry cough. Chest CT reveals increased interstitial markings consistent with pulmonary fibrosis. The medical team reviews the patient's medication history and notes that the patient was recently treated with Methotrexate (MTX). Which statement best describes the mechanism of MTX-induced pneumonitis and its management?
- A) MTX inhibits dihydrofolate reductase, leading to folate depletion and subsequent pulmonary interstitial fibrosis.
- B) The toxicity is due to direct damage from platinum agents; therefore, administering leucovorin rescue therapy is mandatory.
- C) Methotrexate causes lung injury by interfering with the cell cycle in a manner similar to vinca alkaloids.
- D) MTX inhibits dihydrofolate reductase, leading to impaired DNA synthesis and folate depletion, which can manifest as pulmonary fibrosis.
Answer: D. Methotrexate (MTX) is a folic acid antagonist that works by inhibiting the enzyme dihydrofolate reductase ($\text{DHFR}$). This inhibition prevents the regeneration of tetrahydrofolate, leading to functional folate deficiency and impaired DNA synthesis. This systemic depletion can manifest as pulmonary fibrosis or pneumonitis. While MTX toxicity shares mechanisms with other antifolates (like trimethoprim), its specific mechanism is $\text{DHFR}$ inhibition. The rescue therapy for profound bone marrow suppression from MTX is Leucovorin (folinic acid), which bypasses the need for folate synthesis and reverses the myelosuppression.
Quick fire review
What specific organism is a common cause of culture-negative endocarditis?
Coxiella burnetii (associated with Q fever).
What are the four classic manifestations (the 4 Ds) associated with Pelagra, which can result from carcinoid syndrome?
Diarrhea, Dermatitis, Dementia, and Death.
In Ehlers-Danlos Syndrome, besides vascular issues, what is a highly emphasized, unusual complication that must be considered?
Small bowel perforation/explosion.
What type of anemia (MCV) should prompt suspicion for Folate deficiency over B12 deficiency in the setting of malabsorption or alcoholism?
Macrocytic anemia.
When evaluating a patient with microcytic anemia and age > 50, what is the mandatory next step in management?
Colonoscopy (to rule out GI bleeding/colon cancer).
What key precaution must be taken regarding colonoscopy following an acute episode of diverticulitis?
Wait several weeks after the acute episode has resolved; do not perform it during the acute phase.
Which deficiency causes macrocytic anemia and is often associated with alcoholism or hemolytic processes, requiring daily supplementation?
Folate (Vitamin B9).
What class of anti-cancer drugs are known to cause peripheral neuropathy, alongside Vinca Alkaloids?
Taxanes (e.g., Paclitaxel).
Name the three chemotherapy agents associated with pulmonary fibrosis and restrictive lung disease pattern.
Bleomycin, Cisplatin, Methotrexate.
What is the specific rescue agent used to reverse bone marrow suppression caused by Methotrexate toxicity?
Leucovorin (Folinic acid).
In $\alpha_1$-antitrypsin deficiency, what age range is classically associated with the onset of panacinar emphysema?
Early 30s or early 40s.
What type of anemia is typically seen in patients with hemolytic processes (like sickle cell disease) that can lead to folate deficiency?
Macrocytic anemia.
Quick recall / Anki-style questions
Which deficiency causes macrocytic anemia and is often associated with alcoholism or hemolytic processes, requiring daily supplementation?
Folate (Vitamin B9).
What class of anti-cancer drugs are known to cause peripheral neuropathy, alongside Vinca Alkaloids?
Taxanes (e.g., Paclitaxel).
Name the three chemotherapy agents associated with pulmonary fibrosis and restrictive lung disease pattern.
Bleomycin, Cisplatin, Methotrexate.
What is the specific rescue agent used to reverse bone marrow suppression caused by Methotrexate toxicity?
Leucovorin (Folinic acid).
In $\alpha_1$-antitrypsin deficiency, what age range is classically associated with the onset of panacinar emphysema?
Early 30s or early 40s.
What type of anemia is typically seen in patients with hemolytic processes (like sickle cell disease) that can lead to folate deficiency?
Macrocytic anemia.